<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01488396</url>
  </required_header>
  <id_info>
    <org_study_id>336/2549</org_study_id>
    <nct_id>NCT01488396</nct_id>
  </id_info>
  <brief_title>Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye</brief_title>
  <official_title>Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of 0.05% cyclosporin ophthalmic
      emulsion (Restasis) in patients with Stevens-Johnson syndrome that have dry eyes by
      subjective symptoms and signs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stevens-Johnson syndrome patients in chronic stage who have dry eys symptoms and signs will
      be treated with 0.05%cyclosporin ophthalmic emulsion(Restasis)twice a day for 6 months,
      compare results at 0,2,4,6 months include dry eye symptoms, corneal staining (Fluorescein,
      Rose Bengal), Schirmer I,FCT and impression cytology
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>dry eyes symptoms : dryness, gritty, photophobia, burning and pain</measure>
    <time_frame>0, 2, 4, 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Schirmer I test</measure>
    <time_frame>0, 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluorescein clearance test (FCT)</measure>
    <time_frame>0, 6 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal staining</measure>
    <time_frame>0, 2, 4, 6 months</time_frame>
    <description>Staining with fluorescein and rose bengal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluorescein tear break up time</measure>
    <time_frame>0, 2. 4. 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Stevens-Johnson Syndrome</condition>
  <arm_group>
    <arm_group_label>0.05%cyclosporin eye drop</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.05%cyclosporin eye drop</intervention_name>
    <description>use twice daily for 6 months</description>
    <arm_group_label>0.05%cyclosporin eye drop</arm_group_label>
    <other_name>cyclosporin A</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females, of legal age of consent

          -  Patient with Stevens-Johnson syndrome in chronic stage or has symptoms more than 3
             months and has dry eye symptoms

          -  Dry eye symptoms are defined as

               1. has dry eye symptom everyday for more than 3 months

               2. has foreign body sensation frequently

               3. use tear substitutes more than 3 times per day

          -  Tear test shaw abnormalities at least 1 of 2 of following:

               1. Schirmer test without anesthesia is not more than 5 millimeters in 5 minutes

               2. Fluorescein clearance test at first 10 minutes is not more than 3 millimeters and
                  has at least 1 of 3 of the following:

        2.1.Rose Bengal score is not less than 4 2.2.Fluorescein stain at cornea 2.3.Impression
        cytology is consistent to dry eye

          -  Patent punctum

        Exclusion Criteria:

          -  Age &lt; 18 years old

          -  Patients with Steven Johnson syndrome without dry eye

          -  Patients used oral cyclosporine or anticholinergic drug within past 2 months

          -  Patients with HIV or immunocompromise status

          -  Patients with active ocular infections and patients with a history of herpes keratitis

          -  Patients with known or suspected hypersensitivity to any of the ingredients in the
             formula (cyclosporine, glycerin, castor oil, polysorbate 80, carbomer 1342)

          -  Female patients are pregnant or nursing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pinnita Prabhasawat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mahidol university</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 8, 2010</study_first_submitted>
  <study_first_submitted_qc>December 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2011</study_first_posted>
  <last_update_submitted>December 6, 2011</last_update_submitted>
  <last_update_submitted_qc>December 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Pinnita Prabhasawat</investigator_full_name>
    <investigator_title>Associated professor</investigator_title>
  </responsible_party>
  <keyword>Cyclosporin</keyword>
  <keyword>Stevens-Johnson syndrome</keyword>
  <keyword>Dry eye</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Stevens-Johnson Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cyclosporins</mesh_term>
    <mesh_term>Cyclosporine</mesh_term>
    <mesh_term>Ophthalmic Solutions</mesh_term>
    <mesh_term>Tetrahydrozoline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

